LAMC2 and pancreatic intraductal papillary-mucinous neoplasm: It must be noted, however, that the biomarker levels were significantly more elevated in patients with PDAC compared to patients with non-neoplastic conditions, as depicted in Figure 6C,D, with two exceptions: pancreatitis patients had high levels of LAMC2 that were similar to levels in PDAC patients, and PTX3 was already high in IPMN patients.